Pioneering glycoscience for global health
Founded in February 2000, the former Institute for Glycomics was one of Australia’s flagship biomedical research institutes. Located at Griffith University Gold Coast, the institute built a global reputation for its multidisciplinary approach to drug, vaccine and diagnostic discovery—anchored in the expanding field of glycomics.
In 2024, the Institute for Glycomics became a foundational part of the newly established Institute for Biomedicine and Glycomics, continuing its legacy of excellence in glycoscience within a broader biomedical research framework.
Leading the way in glycomics
Glycomics explores the structural and functional properties of carbohydrates (sugars), which play a vital role in human biology.
Every cell in the body is decorated with sugars; understanding their behaviour opened new pathways to treat cancers, infectious diseases and neurodegenerative disorders.
The Institute for Glycomics’ unique expertise and research infrastructure made it the only facility of its kind in Australia, and one of only a handful worldwide.
Research with global impact
From the lab bench to the patient’s bedside, the Institute for Glycomics’ mission was translational. Its researchers led clinical trials for:
- a repurposed drug to treat Ross River virus–induced arthritis
- a novel treatment for sepsis, co-invented by Isititute scientists
- vaccine candidates for malaria and Group A Streptococcus, which progressed to human trials.
These breakthroughs reflected the institute’s commitment to solving real-world health challenges through rigorous science and global collaboration.
Science, strategy and solutions
Under the visionary leadership of Professor Mark von Itzstein AO —a globally recognised pioneer in glycoscience and anti-infective drug discovery—the Institute for Glycomics cultivated a culture of innovation and translational excellence. Supported by Professor Michael Jennings and Dr Chris Davis, the leadership team combined deep scientific expertise with strategic foresight and commercial acumen.
This leadership empowered the institute to transform cutting-edge research into tangible solutions. Through robust partnerships with industry—ranging from local biotech startups to global pharmaceutical companies—the institute’s discoveries were developed into accessible treatments that improved lives worldwide. Today, Professors von Itzstein and Jennings, and Dr Davis continue to drive this mission forward as part of the Institute for Biomedicine and Glycomics, ensuring continuity of vision and impact.
The Institute for Glycomics’ commitment to commercialisation ensured that scientific breakthroughs didn’t remain in the lab, but reached patients and communities where they were needed most.
A collaborative hub of experts and students
With more than 200 members—including researchers, support staff and postgraduate students—the Institute for Glycomics fostered a vibrant and inclusive research environment.
It offered exceptional education programs and attracted talent from across the globe, united by a shared passion for discovery and impact.
Philanthropy, community and celebration
The Institute for Glycomics thrived thanks to the generosity of donors and the strength of its partnerships. Support from organisations such as Rotary District 9640, the Order of St John and Women in Racing helped fund vital research, equipment and clinical trials, making philanthropy a cornerstone of the institute’s success.
To mark its 10th anniversary in 2010, the institute launched Glycomics Week, an annual celebration of research achievements and community engagement. Held every year since, it brought together scientists, students, supporters and the public through events such as the Glycomics Public Forum, Glycomics Student Forum and the Institute for Glycomics Grand Ball.
These events celebrated scientific progress while fostering new connections with schools, companies and international collaborators, reinforcing the institute’s commitment to inclusive, impactful science.
A new era begins
The former Institute for Glycomics now forms a foundational pillar of the newly established Institute for Biomedicine and Glycomics (IBG).
Its legacy of excellence, innovation and global collaboration continues to shape IBG’s mission. The pioneering spirit and commitment to translational science that defined the former Institute for Glycomics remain central to IBG’s vision, ensuring discoveries made here continue to transform lives.
Contact us
Institute for Biomedicine and Glycomics
Griffith University
1 Parklands Dr
Southport QLD 4215
170 Kessels Rd
Nathan QLD 4111
